TABLE 1

Characteristics of the 28 patients treated with peramivira

Clinical characteristicResults for patients with type A influenzaResults for patients with type B (n = 9)
Total (n = 28)bH1N1 pdm09 (n = 6)H3N2 (n = 11)
Age (yr)c4.7 ± 4.1 (2.9, 0.6–14.8)4.0 ± 3.0 (4.0, 0.8–9.2)4.7 ± 5.0 (2.8, 0.6–14.8)6.0 ± 3.9 (6.6, 1.1–11.8)
No. of males17366
No. of vaccinationsd9314
Time after onset (h)c19.0 ± 20.4 (16.0, 3.0–85.5)32.1 ± 30.6 (22.8, 5.0–85.5)11.8 ± 6.8 (9.5, 3.0–22.0)20.3 ± 15.3 (19.3, 3.0–42.0)
Body temp (°C)c39.2 ± 0.7 (39.2, 37.7–40.3)39.5 ± 0.7 (39.8, 38.2–40.0)39.5 ± 0.5 (39.6, 39.0–40.3)38.9 ± 0.7 (38.6, 38.0–39.8)
Duration of fever (h)c26.9 ± 12.0 (27.0, 11.5–43.0)26.5 ± 14.6 (39.0, 11.5–43.0)27.1 ± 11.2 (27.0, 13.0–42.0)25.6 ± 22.7 (17.0, 5.0–66.0)
BUN (mg/dl)c12.3 ± 4.8 (11.6, 3.6–24.0)12.0 ± 6.7 (11.5, 3.6–24.0)12.5 ± 3.8 (11.6, 7.5–20.0)10.6 ± 2.0 (10.5, 8.0–14.0)
Crea (mg/dl)c0.3 ± 0.2 (0.3, 0.2–0.9)0.3 ± 0.1 (0.3, 0.3–0.4)0.4 ± 0.2 (0.3, 0.2–0.9)0.4 ± 0.1 (0.4, 0.2–0.6)
  • a There was no statistically significant difference in clinical characteristics between each group. The Steel-Dwass test was used to analyze age, hours after onset, body temperature, duration of fever, blood urea nitrogen (BUN), and creatinine (Crea); Fisher's exact test was used to analyze sex and vaccination for comparisons between each group.

  • b Two patients with false-positive results on the rapid antigen test were included.

  • c Data are mean ± SD (median, range).

  • d Influenza vaccines were received prior to each influenza season.